174 related articles for article (PubMed ID: 26676313)
1. Earlier diagnosis and strict diets improve the survival rate and clinical course of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency.
Immonen T; Turanlahti M; Paganus A; Keskinen P; Tyni T; Lapatto R
Acta Paediatr; 2016 May; 105(5):549-54. PubMed ID: 26676313
[TBL] [Abstract][Full Text] [Related]
2. Impact of Newborn Screening and Early Dietary Management on Clinical Outcome of Patients with Long Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency and Medium Chain Acyl-CoA Dehydrogenase Deficiency-A Retrospective Nationwide Study.
Rücklová K; Hrubá E; Pavlíková M; Hanák P; Farolfi M; Chrastina P; Vlášková H; Kousal B; Smolka V; Foltenová H; Adam T; Friedecký D; Ješina P; Zeman J; Kožich V; Honzík T
Nutrients; 2021 Aug; 13(9):. PubMed ID: 34578803
[TBL] [Abstract][Full Text] [Related]
3. Peripheral neuropathy in patients with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency - A follow-up EMG study of 12 patients.
Immonen T; Ahola E; Toppila J; Lapatto R; Tyni T; Lauronen L
Eur J Paediatr Neurol; 2016 Jan; 20(1):38-44. PubMed ID: 26653362
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcome, biochemical and therapeutic follow-up in 14 Austrian patients with Long-Chain 3-Hydroxy Acyl CoA Dehydrogenase Deficiency (LCHADD).
Karall D; Brunner-Krainz M; Kogelnig K; Konstantopoulou V; Maier EM; Möslinger D; Plecko B; Sperl W; Volkmar B; Scholl-Bürgi S
Orphanet J Rare Dis; 2015 Feb; 10():21. PubMed ID: 25888220
[TBL] [Abstract][Full Text] [Related]
5. Clinical course and cardiovascular outcomes in patients with the long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency.
Kwiatkowska J; Wierzba J; Karaszewska A; Kozlowski D; Sykut-Cegielska J; Stanko A
Cardiol J; 2017; 24(1):101-104. PubMed ID: 28245050
[No Abstract] [Full Text] [Related]
6. Energy exchangers with LCT as a precision method for diet control in LCHADD.
Mozrzymas R; Konikowska K; Regulska-Ilow B
Adv Clin Exp Med; 2017; 26(3):515-525. PubMed ID: 28791828
[TBL] [Abstract][Full Text] [Related]
7. Most patients with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency develop pathological or subnormal retinal function.
Fahnehjelm KT; Liu Y; Olsson D; Amrén U; Haglind CB; Holmström G; Halldin M; Andreasson S; Nordenström A
Acta Paediatr; 2016 Dec; 105(12):1451-1460. PubMed ID: 27461099
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Chorioretinopathy Associated with Mitochondrial Trifunctional Protein Disorders: Long-Term Follow-up of 21 Cases.
Boese EA; Jain N; Jia Y; Schlechter CL; Harding CO; Gao SS; Patel RC; Huang D; Weleber RG; Gillingham MB; Pennesi ME
Ophthalmology; 2016 Oct; 123(10):2183-95. PubMed ID: 27491397
[TBL] [Abstract][Full Text] [Related]
9. The spectrum of peripheral neuropathy in disorders of the mitochondrial trifunctional protein.
Grünert SC; Eckenweiler M; Haas D; Lindner M; Tsiakas K; Santer R; Tucci S; Spiekerkoetter U
J Inherit Metab Dis; 2021 Jul; 44(4):893-902. PubMed ID: 33638202
[TBL] [Abstract][Full Text] [Related]
10. Serial fatty acid profiles in a preterm infant with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency.
Suganuma H; McPhee AJ; Bratkovic D; Gibson RA; Andersen CC
Pediatr Int; 2019 Apr; 61(4):415-416. PubMed ID: 31025818
[No Abstract] [Full Text] [Related]
11. Increased and early lipolysis in children with long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency during fast.
Haglind CB; Nordenström A; Ask S; von Döbeln U; Gustafsson J; Stenlid MH
J Inherit Metab Dis; 2015 Mar; 38(2):315-22. PubMed ID: 25141826
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of earlier versus later dietary management in long-chain 3-hydroxyacyl-CoA dehydrogenase or mitochondrial trifunctional protein deficiency: a systematic review.
Fraser H; Geppert J; Johnson R; Johnson S; Connock M; Clarke A; Taylor-Phillips S; Stinton C
Orphanet J Rare Dis; 2019 Nov; 14(1):258. PubMed ID: 31730477
[TBL] [Abstract][Full Text] [Related]
13. Effects of fasting, feeding and exercise on plasma acylcarnitines among subjects with CPT2D, VLCADD and LCHADD/TFPD.
Elizondo G; Matern D; Vockley J; Harding CO; Gillingham MB
Mol Genet Metab; 2020; 131(1-2):90-97. PubMed ID: 32928639
[TBL] [Abstract][Full Text] [Related]
14. Fatal pitfalls in newborn screening for mitochondrial trifunctional protein (MTP)/long-chain 3-Hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency.
Lotz-Havla AS; Röschinger W; Schiergens K; Singer K; Karall D; Konstantopoulou V; Wortmann SB; Maier EM
Orphanet J Rare Dis; 2018 Jul; 13(1):122. PubMed ID: 30029694
[TBL] [Abstract][Full Text] [Related]
15. Genetic, biochemical, and clinical spectrum of patients with mitochondrial trifunctional protein deficiency identified after the introduction of newborn screening in the Netherlands.
Schwantje M; Fuchs SA; de Boer L; Bosch AM; Cuppen I; Dekkers E; Derks TGJ; Ferdinandusse S; Ijlst L; Houtkooper RH; Maase R; van der Pol WL; de Vries MC; Verschoof-Puite RK; Wanders RJA; Williams M; Wijburg F; Visser G
J Inherit Metab Dis; 2022 Jul; 45(4):804-818. PubMed ID: 35383965
[TBL] [Abstract][Full Text] [Related]
16. A comprehensive HADHA c.1528G>C frequency study reveals high prevalence of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency in Poland.
Piekutowska-Abramczuk D; Olsen RK; Wierzba J; Popowska E; Jurkiewicz D; Ciara E; Ołtarzewski M; Gradowska W; Sykut-Cegielska J; Krajewska-Walasek M; Andresen BS; Gregersen N; Pronicka E
J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S373-7. PubMed ID: 20814823
[TBL] [Abstract][Full Text] [Related]
17. Retained visual function in a subset of patients with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHADD).
Dulz S; Atiskova Y; Engel P; Wildner J; Tsiakas K; Santer R
Ophthalmic Genet; 2021 Feb; 42(1):23-27. PubMed ID: 33107778
[No Abstract] [Full Text] [Related]
18. Sensory neuronopathy as a major clinical feature of mitochondrial trifunctional protein deficiency in adults.
Nadjar Y; Souvannanorath S; Maisonobe T; Brisset M; De Lonlay P; Schiff M; Viala K; Boutron A; Nicolas G; Laforêt P
Rev Neurol (Paris); 2020 May; 176(5):380-386. PubMed ID: 32253025
[TBL] [Abstract][Full Text] [Related]
19. Impact of newborn screening for fatty acid oxidation disorders on neurological outcome: A Belgian retrospective and multicentric study.
Everard E; Laeremans H; Boemer F; Marie S; Vincent MF; Dewulf JP; Debray FG; De Laet C; Nassogne MC
Eur J Paediatr Neurol; 2024 Mar; 49():60-65. PubMed ID: 38377647
[TBL] [Abstract][Full Text] [Related]
20. An Unusual Case of LCHAD Deficiency Presenting With a Clinical Picture of Hemophagocytic Lymphohistiocytosis: Secondary HLH or Coincidence?
Erdol S; Ture M; Baytan B; Yakut T; Saglam H
J Pediatr Hematol Oncol; 2016 Nov; 38(8):661-662. PubMed ID: 27769081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
